Related Experiment Video
Updated: Mar 16, 2026

Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice
Published on: May 27, 2015
Toll-like receptor 2-mediated MAPKs and NF-κB activation requires the GNAO1-dependent pathway in human mast cells
Meiling Jin1, Bo Yu, Weizhen Zhang
1Center for Diabetes, Obesity and Metabolism, Department of Physiology, Shenzhen University Health Science Center, Shenzhen, Guangdong province 518060, China. echoyyyu@163.com.
Abstract:
Toll-like receptors (TLRs) expressed on mast cells are essential for effective host defense against a wide variety of pathogens. Previous studies have demonstrated that both TLR2 agonists Pam3CSK4 and PGN stimulated IL-8 release in human mast cells. To determine the molecular basis for this phenomenon, we utilized human mast cell line LAD2 cells. We found that only the release of IL-8 stimulated by Pam3CSK4 was TLR2-mediated, which was confirmed by specific TLR2 shRNA. Heterotrimeric G proteins have been previously implicated in TLR signaling in macrophages and monocytes. In the current study, we showed that PamCSK4 induced the activation of MAPKs, NF-κB, PI3K-Akt and Ca(2+)-calcineurin-NFAT signaling cascades in LAD2 cells. Go proteins were required for the activation of MAPKs and NF-κB in TLR2 stimulated LAD2 cells. Therefore, the genetic depletion of Gαo proteins also led to the reduction of the release of IL-8 in LAD2 cells. Taken together, the data presented here suggest that TLR2 activation in human mast cells promotes the release of inflammatory mediators via distinct signaling pathways that partially depend on the action of Go proteins.
Insights
Toll-like receptor 2 (TLR2) activation on human mast cells triggers inflammatory mediator release. This process involves specific signaling pathways, including Go proteins, crucial for IL-8 release.
Area of Science:
- Immunology
- Cell Biology
Background:
- Toll-like receptors (TLRs) on mast cells are vital for pathogen defense.
- Previous research indicated TLR2 agonists Pam3CSK4 and PGN stimulate IL-8 release in human mast cells.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying TLR2-mediated IL-8 release in human mast cells.
- To investigate the role of heterotrimeric G proteins in TLR2 signaling.
Main Methods:
- Utilized the human mast cell line LAD2.
- Employed TLR2 shRNA to confirm TLR2 mediation.
- Analyzed the activation of MAPKs, NF-κB, PI3K-Akt, and Ca(2+)-calcineurin-NFAT signaling pathways.
- Assessed the impact of Go protein depletion on IL-8 release.
Main Results:
- Pam3CSK4-induced IL-8 release was confirmed as TLR2-mediated.
- Pam3CSK4 activated multiple signaling cascades, including MAPKs, NF-κB, PI3K-Akt, and Ca(2+)-calcineurin-NFAT.
- Go proteins were essential for MAPK and NF-κB activation in TLR2-stimulated LAD2 cells.
- Depletion of Go proteins reduced IL-8 release.
Conclusions:
- TLR2 activation in human mast cells initiates inflammatory mediator release through distinct signaling pathways.
- Go proteins play a partial but significant role in TLR2-mediated IL-8 release from mast cells.
Related Concept Videos
MAPK Signaling Cascades
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Amplifying Signals via Second Messengers
NF-kB-dependent Signaling Pathway
Inflammation
TGF - β Signaling Pathway

